{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T10:35:36Z","timestamp":1788863736122,"version":"build-2803163510"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2005,4,26]],"date-time":"2005-04-26T00:00:00Z","timestamp":1114473600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2005,7]]},"DOI":"10.1007\/s00467-004-1795-3","type":"journal-article","created":{"date-parts":[[2005,4,27]],"date-time":"2005-04-27T13:53:41Z","timestamp":1114610021000},"page":"854-857","source":"Crossref","is-referenced-by-count":67,"title":["Tuberous sclerosis and the kidney: from mesenchyme to epithelium, and beyond"],"prefix":"10.1007","volume":"20","author":[{"given":"Elizabeth Petri","family":"Henske","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2005,4,26]]},"reference":[{"key":"1795_CR1","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/S0025-6196(12)61196-3","volume":"66","author":"Shepherd","year":"1991","unstructured":"Shepherd CW, Gomez MR, Lie JT, Crowson CS (1991) Causes of death in patients with tuberous sclerosis. Mayo Clin Proc 66:792\u2013796","journal-title":"Mayo Clin Proc"},{"key":"1795_CR2","first-page":"1490","volume":"351","author":"O","year":"1998","unstructured":"O\u2019Callaghan FJK, Shiell AW, Osborne JP, Martyn CN (1998) Prevalence of tuberous sclerosis estimated by capture-recapture analysis. Lancet 351:1490","journal-title":"Lancet"},{"key":"1795_CR3","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1086\/302381","volume":"64","author":"Jones","year":"1999","unstructured":"Jones AC, Shyamsundar MM, Thomas MW, Maynard J, Idziaszczyk S, Tomkins S, Sampson JR, Cheadle JP (1999) Comprehensive mutation analysis of TSC1 and TSC2-and phenotypic correlations in 150 families with tuberous sclerosis. Am J Hum Genet 64:1305\u20131315","journal-title":"Am J Hum Genet"},{"key":"1795_CR4","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1126\/science.277.5327.805","volume":"277","author":"van","year":"1997","unstructured":"van Slegtenhorst M, de Hoogt R, Hermans C, Nellist M, Janssen B, Verhoef S, Lindhout D, van den Ouweland A, Halley D, Young J, Burley M, Jeremiah S, Woodward K, Nahmias J, Fox M, Ekong R, Osborne J, Wolfe J, Povey S, Snell R, Cheadle J, Jones A, Tachataki M, Ravine D, Sampson J, Reeve M, Richardson P, Wilmer R, Munro C, Hawkins T, Sepp T, Ali J, Ward S, Green A, Yates J, Kwiatkowska J, Henske E, Short M, Haines J, Jozwiak S, Kwiatkowski D (1997) Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34. Science 277:805\u2013808","journal-title":"Science"},{"key":"1795_CR5","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/0092-8674(93)90618-Z","volume":"75","author":"European","year":"1993","unstructured":"European Chromosome 16 Tuberous Sclerosis Consortium (1993) Identification and characterization of the tuberous sclerosis gene on chromosome 16. Cell 75:1305\u20131315","journal-title":"Cell"},{"key":"1795_CR6","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1086\/316951","volume":"68","author":"Dabora","year":"2001","unstructured":"Dabora SL, Jozwiak S, Franz DN, Roberts PS, Nieto A, Chung J, Choy YS, Reeve MP, Thiele E, Egelhoff JC, Kasprzyk-Obara J, Domanska-Pakiela D, Kwiatkowski DJ (2001) Mutational analysis in a cohort of 224 tuberous sclerosis patients indicates increased severity of TSC2, compared with TSC1, disease in multiple organs. Am J Hum Genet 68:64\u201380","journal-title":"Am J Hum Genet"},{"key":"1795_CR7","first-page":"1201","volume":"149","author":"Bjornsson","year":"1996","unstructured":"Bjornsson J, Short MP, Kwiatkowski DJ, Henske EP (1996) Tuberous sclerosis-associated renal cell carcinoma. Clinical, pathological, and genetic features. Am J Pathol 149:1201\u20131208","journal-title":"Am J Pathol"},{"key":"1795_CR8","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1093\/hmg\/3.10.1829","volume":"3","author":"Carbonara","year":"1994","unstructured":"Carbonara C, Longa L, Grosso E, Borrone C, Garre M, Brisigotti M, Migone N (1994) 9q34 loss of heterozygosity in a tuberous sclerosis astrocytoma suggests a growth suppressor-like activity also for the TSC1 gene. Hum Mol Genet 3:1829\u20131832","journal-title":"Hum Mol Genet"},{"key":"1795_CR9","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1093\/hmg\/3.10.1833","volume":"3","author":"Green","year":"1994","unstructured":"Green A, Johnson P, Yates J (1994) The tuberous sclerosis gene on chromosome 9q34 acts as a growth suppressor. Hum Mol Genet 3:1833\u20131834","journal-title":"Hum Mol Genet"},{"key":"1795_CR10","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/ng0294-193","volume":"6","author":"Green","year":"1994","unstructured":"Green AJ, Smith M, Yates JR (1994) Loss of heterozygosity on chromosome 16p13.3 in hamartomas from tuberous sclerosis patients. Nat Genet 6:193\u2013196","journal-title":"Nat Genet"},{"key":"1795_CR11","first-page":"400","volume":"59","author":"Henske","year":"1996","unstructured":"Henske EP, Scheithauer BW, Short MP, Wollmann R, Nahmias J, Hornigold N, van Slegtenhorst M, Welsh CT, Kwiatkowski DJ (1996) Allelic loss is frequent in tuberous sclerosis kidney lesions but rare in brain lesions. Am J Hum Genet 59:400\u2013406","journal-title":"Am J Hum Genet"},{"key":"1795_CR12","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0022-5347(01)63072-6","volume":"160","author":"Ewalt","year":"1998","unstructured":"Ewalt DH, Sheffield E, Sparagana SP, Delgado MR, Roach ES (1998) Renal lesion growth in children with tuberous sclerosis complex. J Urol 160:141\u2013145","journal-title":"J Urol"},{"key":"1795_CR13","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/ng1294-328","volume":"8","author":"Brook-Carter","year":"1994","unstructured":"Brook-Carter PT, Peral B, Ward CJ, Thompson P, Hughes J, Maheshwar MM, Nellist M, Gamble V, Harris PC, Sampson JR (1994) Deletion of the TSC2 and PKD1 genes associated with severe infantile polycystic kidney disease\u2014a contiguous gene syndrome. Nat Genet 8:328\u2013332","journal-title":"Nat Genet"},{"key":"1795_CR14","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S0002-9440(10)63840-0","volume":"162","author":"Cai","year":"2003","unstructured":"Cai S, Everitt JI, Kugo H, Cook J, Kleymenova E, Walker CL (2003) Polycystic kidney disease as a result of loss of the tuberous sclerosis 2 tumor suppressor gene during development. Am J Pathol 162:457\u2013468","journal-title":"Am J Pathol"},{"key":"1795_CR15","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1172\/JCI119147","volume":"99","author":"Brasier","year":"1997","unstructured":"Brasier JL, Henske EP (1997) Loss of the polycystic kidney disease (PKD1) region of chromosome 16p13 in renal cyst cells supports a loss-of-function model for cyst pathogenesis. J Clin Invest 99:194\u2013199","journal-title":"J Clin Invest"},{"key":"1795_CR16","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/S1097-2765(01)00226-X","volume":"7","author":"Kleymenova","year":"2001","unstructured":"Kleymenova E, Ibraghimov-Beskrovnaya O, Kugoh H, Everitt J, Xu H, Kiguchi K, Landes G, Harris P, Walker C (2001) Tuberin-dependent membrane localization of polycystin-1: a functional link between polycystic kidney disease and the TSC2 tumor suppressor gene. Mol Cell 7:823\u2013832","journal-title":"Mol Cell"},{"key":"1795_CR17","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1002\/(SICI)1097-0142(19981115)83:10<2208::AID-CNCR21>3.0.CO;2-K","volume":"83","author":"Al-Saleem","year":"1998","unstructured":"Al-Saleem T, Wessner LL, Scheithauer BW, Patterson K, Roach ES, Dreyer SJ, Fujikawa K, Bjornsson J, Bernstein J, Henske EP (1998) Malignant tumors of the kidney, brain, and soft tissues in children and young adults with the tuberous sclerosis complex. Cancer 83:2208\u20132216","journal-title":"Cancer"},{"key":"1795_CR18","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/0090-4295(91)80261-5","volume":"37","author":"Washecka","year":"1991","unstructured":"Washecka R, Hanna M (1991) Malignant renal tumors in tuberous sclerosis. Urology 37:340\u2013343","journal-title":"Urology"},{"key":"1795_CR19","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/S0022-3468(96)90689-2","volume":"31","author":"Robertson","year":"1996","unstructured":"Robertson FM, Cendron M, Klauber GT, Harris BH (1996) Renal cell carcinoma in association with tuberous sclerosis in children. J Pediatr Surg 31:729\u2013730","journal-title":"J Pediatr Surg"},{"key":"1795_CR20","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1007\/s00247-002-0765-9","volume":"32","author":"Breysem","year":"2002","unstructured":"Breysem L, Nijs E, Proesmans W, Smet MH (2002) Tuberous sclerosis with cystic renal disease and multifocal renal cell carcinoma in a baby girl. Pediatr Radiol 32:677\u2013680","journal-title":"Pediatr Radiol"},{"key":"1795_CR21","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0720-048X(97)00037-5","volume":"27","author":"Tello","year":"1998","unstructured":"Tello R, Blickman JG, Buonomo C, Herrin J (1998) Meta analysis of the relationship between tuberous sclerosis complex and renal cell carcinoma. Eur J Radiol 27:131\u2013138","journal-title":"Eur J Radiol"},{"key":"1795_CR22","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1111\/j.1523-1755.2004.00838.x","volume":"66","author":"Bissler","year":"2004","unstructured":"Bissler JJ, Kingswood JC (2004) Renal angiomyolipomata. Kidney Int 66:924\u2013934","journal-title":"Kidney Int"},{"key":"1795_CR23","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1097\/00000478-199806000-00003","volume":"22","author":"Martignoni","year":"1998","unstructured":"Martignoni G, Pea M, Bonetti F, Zamboni G, Carbonara C, Longa L, Zancanaro C, Maran M, Brisigotti M, Mariuzzi GM (1998) Carcinomalike monotypic epithelioid angiomyolipoma in patients without evidence of tuberous sclerosis: a clinicopathologic and genetic study. Am J Surg Pathol 22:663\u2013672","journal-title":"Am J Surg Pathol"},{"key":"1795_CR24","first-page":"277","volume":"1","author":"Al-Saleem","year":"2001","unstructured":"Al-Saleem T, Kizilbash N, Bjornsson J, Patchefsky A, Eisenberg B, Hanks G, Greenberg R, Henske EP (2001) Renal angiomyolipoma mimicking malignancy. A challenging problem in uro-oncology. Urol Oncol 1:277\u2013283","journal-title":"Urol Oncol"},{"key":"1795_CR25","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1097\/00000478-199802000-00005","volume":"22","author":"Pea","year":"1998","unstructured":"Pea M, Bonetti F, Martignoni G, Henske EP, Manfrin E, Colato C, Bernstein J (1998) Apparent renal cell carcinomas in tuberous sclerosis are heterogeneous: the identification of malignant epithelioid angiomyolipoma. Am J Surg Pathol 22:180\u2013187","journal-title":"Am J Surg Pathol"},{"key":"1795_CR26","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1097\/00000478-200006000-00017","volume":"24","author":"Martignoni","year":"2000","unstructured":"Martignoni G, Pea M, Rigaud G, Manfrin E, Colato C, Zamboni G, Scarpa A, Tardanico R, Roncalli M, Bonetti F (2000) Renal angiomyolipoma with epithelioid sarcomatous transformation and metastases: demonstration of the same genetic defects in the primary and metastatic lesions. Am J Surg Pathol 24:889\u2013894","journal-title":"Am J Surg Pathol"},{"key":"1795_CR27","first-page":"4766","volume":"58","author":"Plank","year":"1998","unstructured":"Plank TL, Yeung RS, Henske EP (1998) Hamartin, the product of the tuberous sclerosis 1 (TSC1) gene, interacts with tuberin and appears to be localized to cytoplasmic vesicles. Cancer Res 58:4766\u20134770","journal-title":"Cancer Res"},{"key":"1795_CR28","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1093\/hmg\/7.6.1053","volume":"7","author":"van","year":"1998","unstructured":"van Slegtenhorst M, Nellist M, Nagelkerken B, Cheadle J, Snell R, van den Ouweland A, Reuser A, Sampson J, Halley D, van der Sluijs P (1998) Interaction between hamartin and tuberin, the TSC1 and TSC2 gene products. Hum Mol Genet 7:1053\u20131057","journal-title":"Hum Mol Genet"},{"key":"1795_CR29","doi-asserted-by":"crossref","first-page":"3151","DOI":"10.1038\/sj.onc.1207542","volume":"23","author":"Fingar","year":"2004","unstructured":"Fingar DC, Blenis J (2004) Target of rapamycin (TOR): an integrator of nutrient and growth factor signals and coordinator of cell growth and cell cycle progression. Oncogene 23:3151\u20133171","journal-title":"Oncogene"},{"key":"1795_CR30","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S0002-9440(10)63843-6","volume":"162","author":"Karbowniczek","year":"2003","unstructured":"Karbowniczek M, Yu J, Henske EP (2003) Renal angiomyolipomas from patients with sporadic lymphangiomyomatosis contain both neoplastic and non-neoplastic vascular structures. Am J Pathol 162:491\u2013500","journal-title":"Am J Pathol"},{"key":"1795_CR31","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1016\/S0140-6736(03)13044-9","volume":"361","author":"El-Hashemite","year":"2003","unstructured":"El-Hashemite N, Zhang H, Henske EP, Kwiatkowski DJ (2003) Mutation in TSC2 and activation of mammalian target of rapamycin signalling pathway in renal angiomyolipoma. Lancet 361:1348\u20131349","journal-title":"Lancet"},{"key":"1795_CR32","doi-asserted-by":"crossref","unstructured":"Yu J, Astrinidis A, Howard S, Henske EP (2003) Estradiol and tamoxifen stimulate lymphangiomyomatosis-associated angiomyolipoma cell growth and activate both genomic and non-genomic signaling pathways. Am J Physiol Lung Cell Mol Physiol","DOI":"10.1152\/ajplung.00204.2003"},{"key":"1795_CR33","doi-asserted-by":"crossref","first-page":"6356","DOI":"10.1038\/sj.onc.1205792","volume":"21","author":"Im","year":"2002","unstructured":"Im E, von Lintig FC, Chen J, Zhuang S, Qui W, Chowdhury S, Worley PF, Boss GR, Pilz RB (2002) Rheb is in a high activation state and inhibits B-Raf kinase in mammalian cells. Oncogene 21:6356\u20136365","journal-title":"Oncogene"},{"key":"1795_CR34","doi-asserted-by":"crossref","unstructured":"Karbowniczek M, Cash T, Cheung M, Robertson GP, Astrinidis A, Henske EP (2004) Regulation of B-Raf kinase activity by tuberin and Rheb is mTOR independent. J Biol Chem","DOI":"10.1074\/jbc.M402591200"},{"key":"1795_CR35","doi-asserted-by":"crossref","first-page":"51372","DOI":"10.1074\/jbc.M303956200","volume":"278","author":"Astrinidis","year":"2003","unstructured":"Astrinidis A, Senapedis W, Coleman TR, Henske EP (2003) Cell cycle-regulated phosphorylation of hamartin, the product of the tuberous sclerosis complex 1 gene, by cyclin-dependent kinase 1\/cyclin B. J Biol Chem 278:51372\u201351379","journal-title":"J Biol Chem"},{"key":"1795_CR36","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/S0092-8674(03)00929-2","volume":"115","author":"Inoki","year":"2003","unstructured":"Inoki K, Zhu T, Guan KL (2003) TSC2 mediates cellular energy response to control cell growth and survival. Cell 115:577\u2013590","journal-title":"Cell"},{"key":"1795_CR37","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1086\/321972","volume":"69","author":"Niida","year":"2001","unstructured":"Niida Y, Stemmer-Rachamimov AO, Logrip M, Tapon D, Perez R, Kwiatkowski DJ, Sims K, MacCollin M, Louis DN, Ramesh V (2001) Survey of somatic mutations in tuberous sclerosis complex (TSC) hamartomas suggests different genetic mechanisms for pathogenesis of TSC lesions. Am J Hum Genet 69:493\u2013503","journal-title":"Am J Hum Genet"},{"key":"1795_CR38","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/35010550","volume":"2","author":"Lamb","year":"2000","unstructured":"Lamb RF, Roy C, Diefenbach TJ, Vinters HV, Johnson MW, Jay DG, Hall A (2000) The TSC1 tumour suppressor hamartin regulates cell adhesion through ERM proteins and the GTPase Rho. Nat Cell Biol 2:281\u2013287","journal-title":"Nat Cell Biol"},{"key":"1795_CR39","doi-asserted-by":"crossref","first-page":"8470","DOI":"10.1038\/sj.onc.1205962","volume":"21","author":"Astrinidis","year":"2002","unstructured":"Astrinidis A, Cash TP, Hunter DS, Walker CL, Chernoff J, Henske EP (2002) Tuberin, the tuberous sclerosis complex 2 tumor suppressor gene product, regulates Rho activation, cell adhesion, and migration. Oncogene 21:8470\u20138476","journal-title":"Oncogene"},{"key":"1795_CR40","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S1535-6108(03)00187-9","volume":"4","author":"Brugarolas","year":"2003","unstructured":"Brugarolas JB, Vazquez F, Reddy A, Sellers WR, Kaelin WG Jr (2003) TSC2 regulates VEGF through mTOR-dependent and -independent pathways. Cancer Cell 4:147\u2013158","journal-title":"Cancer Cell"},{"key":"1795_CR41","first-page":"2675","volume":"63","author":"Liu","year":"2003","unstructured":"Liu MY, Poellinger L, Walker CL (2003) Up-regulation of hypoxia-inducible factor 2alpha in renal cell carcinoma associated with loss of Tsc-2 tumor suppressor gene. Cancer Res 63:2675\u20132680","journal-title":"Cancer Res"},{"key":"1795_CR42","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1097\/01.ju.0000096060.92397.ed","volume":"170","author":"Linehan","year":"2003","unstructured":"Linehan WM, Walther MM, Zbar B (2003) The genetic basis of cancer of the kidney. J Urol 170:2163\u20132172","journal-title":"J Urol"},{"key":"1795_CR43","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/modpathol.3880517","volume":"15","author":"Duffy","year":"2002","unstructured":"Duffy K, Al-Saleem T, Karbowniczek M, Ewalt D, Prowse AH, Henske EP (2002) Mutational analysis of the von Hippel-Lindau gene in clear cell renal carcinomas from tuberous sclerosis complex patients. Mod Pathol 15:205\u2013210","journal-title":"Mod Pathol"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-004-1795-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00467-004-1795-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-004-1795-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,7]],"date-time":"2020-04-07T02:52:45Z","timestamp":1586227965000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00467-004-1795-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,4,26]]},"references-count":43,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2005,7]]}},"alternative-id":["1795"],"URL":"https:\/\/doi.org\/10.1007\/s00467-004-1795-3","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,4,26]]}}}